Omada Health (OMDA) Competitors $17.67 -0.25 (-1.40%) As of 07/11/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock OMDA vs. LFST, PGNY, NHC, GRAL, TDOC, VRDN, AHCO, CDNA, AGL, and PNTGShould you be buying Omada Health stock or one of its competitors? The main competitors of Omada Health include LifeStance Health Group (LFST), Progyny (PGNY), National HealthCare (NHC), GRAIL (GRAL), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Agilon Health (AGL), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry. Omada Health vs. Its Competitors LifeStance Health Group Progyny National HealthCare GRAIL Teladoc Health Viridian Therapeutics AdaptHealth CareDx Agilon Health The Pennant Group Omada Health (NASDAQ:OMDA) and LifeStance Health Group (NASDAQ:LFST) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk. Which has higher valuation & earnings, OMDA or LFST? Omada Health has higher earnings, but lower revenue than LifeStance Health Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmada HealthN/AN/AN/AN/AN/ALifeStance Health Group$1.25B1.40-$57.44M-$0.10-45.10 Is OMDA or LFST more profitable? Omada Health has a net margin of 0.00% compared to LifeStance Health Group's net margin of -2.78%. Omada Health's return on equity of 0.00% beat LifeStance Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Omada HealthN/A N/A N/A LifeStance Health Group -2.78%-2.47%-1.69% Do analysts rate OMDA or LFST? Omada Health currently has a consensus target price of $23.86, indicating a potential upside of 35.01%. LifeStance Health Group has a consensus target price of $8.50, indicating a potential upside of 88.47%. Given LifeStance Health Group's higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than Omada Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omada Health 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00LifeStance Health Group 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.83 Do insiders and institutionals believe in OMDA or LFST? 85.5% of LifeStance Health Group shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media favor OMDA or LFST? In the previous week, Omada Health had 2 more articles in the media than LifeStance Health Group. MarketBeat recorded 8 mentions for Omada Health and 6 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.86 beat Omada Health's score of 0.46 indicating that LifeStance Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LifeStance Health Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOmada Health and LifeStance Health Group tied by winning 6 of the 12 factors compared between the two stocks. Get Omada Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMDA vs. The Competition Export to ExcelMetricOmada HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$461.44M$7.37B$5.62B$9.10BDividend YieldN/A2.81%5.24%4.00%P/E RatioN/A33.8228.1320.27Price / SalesN/A35.57428.6398.72Price / CashN/A23.3737.4658.16Price / BookN/A6.858.045.49Net IncomeN/A$233.05M$3.18B$250.45M7 Day Performance-5.15%0.01%3.62%4.78%1 Month PerformanceN/A0.25%4.05%7.67%1 Year PerformanceN/A33.80%30.00%16.43% Omada Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMDAOmada HealthN/A$17.67-1.4%$23.86+35.0%N/A$461.44MN/A0.00849Analyst ForecastQuiet Period ExpirationLFSTLifeStance Health Group3.1412 of 5 stars$4.71-1.8%$8.50+80.7%-17.9%$1.83B$1.25B-47.0510,218News CoveragePGNYProgyny1.1001 of 5 stars$21.29-0.8%$23.45+10.2%-17.6%$1.82B$1.17B37.33310Trending NewsAnalyst UpgradeAnalyst RevisionNHCNational HealthCareN/A$107.41-0.9%N/A-13.9%$1.66B$1.37B13.4612,400News CoveragePositive NewsGRALGRAIL0.656 of 5 stars$44.58-4.6%$31.50-29.3%+179.5%$1.60B$125.60M-0.731,360TDOCTeladoc Health2.6672 of 5 stars$8.06-2.8%$9.60+19.1%-11.1%$1.41B$2.57B-1.365,500News CoverageAnalyst ForecastGap DownVRDNViridian Therapeutics3.222 of 5 stars$15.61-0.4%$37.56+140.6%+31.6%$1.27B$300K-4.0550News CoveragePositive NewsAHCOAdaptHealth3.3219 of 5 stars$9.23-1.0%$13.40+45.2%-11.9%$1.25B$3.26B16.2510,500CDNACareDx4.2699 of 5 stars$18.60-3.3%$30.33+63.1%+27.6%$1.04B$333.79M16.17740Positive NewsInsider TradeAGLAgilon Health2.3254 of 5 stars$2.35-3.5%$4.79+104.1%-63.7%$983.13M$6.06B-3.991,076Analyst ForecastPNTGThe Pennant Group3.4011 of 5 stars$25.98-1.2%$34.60+33.2%-2.1%$895.53M$695.24M34.187,000 Related Companies and Tools Related Companies LifeStance Health Group Competitors Progyny Competitors National HealthCare Competitors GRAIL Competitors Teladoc Health Competitors Viridian Therapeutics Competitors AdaptHealth Competitors CareDx Competitors Agilon Health Competitors The Pennant Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OMDA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omada Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omada Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
